The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity

被引:0
作者
Parren, PWHI
Moore, JP
Burton, DR
Sattentau, QJ
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[3] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA
[4] Ctr Immunol, Marseille, France
关键词
HIV; gp120; gp41; neutralization; vaccine;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:S137 / S162
页数:26
相关论文
共 316 条
[1]   CARBOHYDRATE DRAMATICALLY INFLUENCES IMMUNE REACTIVITY OF ANTISERA TO VIRAL GLYCOPROTEIN ANTIGENS [J].
ALEXANDER, S ;
ELDER, JH .
SCIENCE, 1984, 226 (4680) :1328-1330
[2]   EXPRESSION AND CHARACTERIZATION OF CD4-IGG(2), A NOVEL HETEROTETRAMER THAT NEUTRALIZES PRIMARY HIV TYPE-1 ISOLATES [J].
ALLAWAY, GP ;
DAVISBRUNO, KL ;
BEAUDRY, GA ;
GARCIA, EB ;
WONG, EL ;
RYDER, AM ;
HASEL, KW ;
GAUDUIN, MC ;
KOUP, RA ;
MCDOUGAL, JS ;
MADDON, PJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) :533-539
[3]   Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities [J].
Alsmadi, O ;
Tilley, SA .
JOURNAL OF VIROLOGY, 1998, 72 (01) :286-293
[4]   A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection [J].
Alsmadi, O ;
Herz, R ;
Murphy, E ;
Pinter, A ;
Tilley, SA .
JOURNAL OF VIROLOGY, 1997, 71 (02) :925-933
[5]   Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: Isolation of a neutralization escape variant [J].
Andrus, L ;
Prince, AM ;
Bernal, I ;
McCormack, P ;
Lee, DH ;
Gorny, MK ;
Zolla-Pazner, S .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) :889-897
[6]   Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1 [J].
Armstrong, SJ ;
McInerney, TL ;
McLain, L ;
Wahren, B ;
Hinkula, J ;
Levi, M ;
Dimmock, NJ .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :2931-2941
[7]   MACAQUES IMMUNIZED WITH HLA-DR ARE PROTECTED FROM CHALLENGE WITH SIMIAN IMMUNODEFICIENCY VIRUS [J].
ARTHUR, LO ;
BESS, JW ;
URBAN, RG ;
STROMINGER, JL ;
MORTON, WR ;
MANN, DL ;
HENDERSON, LE ;
BENVENISTE, RE .
JOURNAL OF VIROLOGY, 1995, 69 (05) :3117-3124
[8]   AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION [J].
BACK, NKT ;
SMIT, L ;
DEJONG, JJ ;
KEULEN, W ;
SCHUTTEN, M ;
GOUDSMIT, J ;
TERSMETTE, M .
VIROLOGY, 1994, 199 (02) :431-438
[9]   SERUM NEUTRALIZATION OF FELINE IMMUNODEFICIENCY VIRUS IS MARKEDLY DEPENDENT ON PASSAGE HISTORY OF THE VIRUS AND HOST SYSTEM [J].
BALDINOTTI, F ;
MATTEUCCI, D ;
MAZZETTI, P ;
GIANNELLI, C ;
BANDECCHI, P ;
TOZZINI, F ;
BENDINELLI, M .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4572-4579
[10]   Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells [J].
Baldridge, JR ;
McGraw, TS ;
Paoletti, A ;
Buchmeier, MJ .
JOURNAL OF VIROLOGY, 1997, 71 (01) :755-758